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Abstract
Conventional dendritic cells (cDC) are bone marrow- derived immune cells that play 
a central role in linking innate and adaptive immunity. cDCs efficiently uptake, pro-
cess and present antigen to naïve T cells, driving clonal expansion of antigen- specific 
T- cell responses. In chicken, vital reagents are lacking for the efficient and precise 
identification of cDCs. In this study, we have developed several novel reagents for 
the identification and characterization of chicken cDCs. Chicken FLT3 cDNA was 
cloned and a monoclonal antibody to cell surface FLT3 was generated. This anti-
body identified a distinct FLT3HI splenic subset which lack expression of signature 
markers for B cells, T cells or monocyte/macrophages. By combining anti- FLT3 and 
CSF1R- eGFP transgenic expression, three major populations within the mononu-
clear phagocyte system were identified in the spleen. The cDC1 subset of mamma-
lian cDCs express the chemokine receptor XCR1. To characterize chicken cDCs, a 
synthetic chicken chemokine (C motif) ligand (XCL1) peptide conjugated to Alexa 
Fluor 647 was developed (XCL1AF647). Flow cytometry staining of XCL1AF647 on 
splenocytes showed that all chicken FLT3HI cells exclusively express XCR1, support-
ing the hypothesis that this population comprises bona fide chicken cDCs. Further 
analysis revealed that chicken cDCs expressed CSF1R but lacked the expression 
of CSF2R. Collectively, the cell surface phenotypes of chicken cDCs were partially 
conserved with mammalian XCR1+ cDC1, with distinct differences in CSF1R and 
CSF2R expression compared with mammalian orthologues. These original reagents 
allow the efficient identification of chicken cDCs to investigate their important roles 
in the chicken immunity and diseases.
K E Y W O R D S
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INTRODUCTION
T cell- mediated immunity in birds, as in mammals, re-
quires antigen uptake and presentation. While immune 
cell types including macrophages, monocytes and B cells 
can act as antigen- presenting cells (APCs), cDCs are 
thought to have a central role in the maintenance of tol-
erance and induction of immune responses against patho-
gens due to their capacity to initiate primary immune 
responses by driving the proliferation of naïve T cells [1- 3]. 
Mammalian cDC development largely occurs in the bone 
marrow (BM) and involves a developmental cascade of 
BM- resident haematopoietic stem cell- derived precursor 
and progenitor cells [4,5]. In the steady state, mammalian 
cDC populations in peripheral tissues are maintained by 
pre- cDCs or cDCs entering tissues from the blood and di-
viding locally [6]. In mammals, the prevailing paradigm in 
cDC biology is that after encountering antigen and being 
activated in peripheral tissues, they migrate via lymphatic 
vessels to draining lymph nodes where they initiate T- cell- 
dependent immune responses [4,7]. Birds do not have spe-
cialized lymph nodes: avian secondary lymphoid tissues 
largely consist of poorly characterized dispersed lymphoid 
follicles in mucosal tissues and the skin, as well as avian- 
specific mucosal lymphoid organs, such as the caecal 
tonsils [8- 10]. In contrast to the mammalian lymph node 
based local immune responses, in birds it is hypothesized 
that antigen presentation occurs locally within tissues 
[11]. The precise nature and mechanisms of this antigen 
presentation are currently unknown.
The development of the cDC lineage (cDCpoiesis) in 
mammals is controlled by the growth factor Fms- related 
tyrosine- kinase 3  ligand (Flt3L) and its cognate recep-
tor FLT3 [12]. Mammalian cDCs consist of two subsets: 
cDC1 and cDC2 [13]. Each cDC subset exhibits functional 
specialization, which is further influenced by tissue mi-
croenvironment [12,14- 17]. The cDC1  subset excel at 
cross- presentation of exogenous microbial and tumour 
antigens to efficiently prime CD8+ T cells and activate 
CD4+ T cells through MHC class II antigen (MHCII) pre-
sentation resulting in the polarization of activated CD4+ 
T cells towards a Th1 phenotype [18- 21]. The mammalian 
cDC2  subset exhibits less functional specialization, pro-
moting a wide range of immune responses [22- 24]. The 
literature is somewhat confused by the use of the term 
‘DC’ to describe APCs that can be generated by cultiva-
tion of monocytes or bone marrow cells in CSF2, although 
monocytes are generally regarded as a separate lineage 
from cDC [13,25].
Using transcriptomic approaches, a chicken immune 
cell population expressing genes associated with the 
mammalian cDC1  subset (including XCR1, FLT3, CIITA, 
ZBTB46, ID2, IRF8, CADM1) has been identified in the 
spleen, liver and lungs [26- 29]. However, due to the limited 
availability of avian reagents compared with mammalian 
species, it is unclear whether chickens have cell population 
equivalent to the mammalian cDC2 subsets, nor whether 
avian- specific dendritic cell subsets exist. As birds lack 
lymph nodes, it is not clear whether chicken cDCpoiesis 
proceeds in the same manner as observed in mammals, 
nor how chicken cDCs perform the same basic functions 
of immune surveillance and antigen presentation as their 
mammalian counterparts in a radically different lymphoid 
tissue environment. Addressing these outstanding ques-
tions will require the production of immunological tools to 
identify and characterize chicken cDCs.
To address this resource gap, we previously generated 
antibodies against chicken CSF1 [30] and CSF1R [31] and 
demonstrated that labelled recombinant chicken CSF1 
could bind to CSF1R- positive cells [30]. In the current 
study, we describe the production and characterization of a 
novel anti- chicken FLT3 monoclonal antibody and show its 
applications in the flow cytometric analysis and immuno-
fluorescent staining of chicken tissue cDCs. Furthermore, 
we also generated reagents to label the cell surface recep-
tors XCR1 and CSF2R, which, in combination with the 
anti- chicken FLT3  monoclonal antibody, allowed us to 
efficiently phenotypically characterize the chicken cDC. 
We show that the chicken spleen contains several FLT3+ 
cell populations, with the XCR1+ FLT3HI subset likely rep-
resenting the bona fide chicken cDC population. In com-
bination with a previously generated CSF1R- transgenic 
chicken line [10], a more detailed flow cytometry analysis 
revealed that the cell surface phenotypes of chicken XCR1+ 
cDC were partially conserved with the mammalian XCR1+ 
cDC1 subset, with distinct differences in CSF1R and CSF2R 
expression compared with mammalian orthologues. 
We show that while Salmonella Typhimurium invades 
chicken FLT3HI cDCs, they exhibit preferentially trophism 
for splenic macrophages. Finally, we show that the in vitro 
bone marrow- derived DCs (BMDCs) expresses the classi-
cal chicken monocyte/macrophage marker MRC1L- B and 
do not express either FLT3 or XCR1, indicating that these 
are more accurately described as antigen- presenting mac-
rophages rather than DC.
MATERIALS AND METHODS
Chickens and ethics statement
All birds were obtained from the National Avian Research 
Facility at The Roslin Institute, University of Edinburgh. 
All birds were hatched and housed in premises licensed 
under a UK Home Office Establishment License in full 
compliance with the Animals (Scientific Procedures) Act 
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1986 and the Code of Practice for Housing and Care of 
Animals Bred, Supplied or Used for Scientific Purposes. 
Production of the CSF1R- eGFP reporter transgenic line 
has been previously described [10]. This transgenic line 
has been used for various studies of mononuclear phago-
cyte development [28,32- 34]. Breeding of transgenic chick-
ens was carried out under the authority of Project License 
PPL 70/8940 with the consent of The Roslin Institute 
Animal Welfare and Ethical Review Board. Animals were 
humanely culled in accordance with Schedule 1 of the 
Animals (Scientific Procedures) Act 1986.
Amplification of the full- length chicken 
FLT3 gene and a short isoform
To obtain accurate sequence data for the 5’end of FLT3, 
it was firstly cloned by a mismatch RT- PCR. Briefly, 
total RNA was extracted from splenocytes from a 
6- week- old J line bird using TRIzol reagent (Invitrogen, 
Thermo Fisher Scientific), mRNA was then purified 
with Dynabeads Oligo (dT)25 (Invitrogen, Thermo Fisher 
Scientific), as per manufacturer's instruction. 2 µg mRNA 
was then used to create a double- strand cDNA library 
using Marathon® cDNA Amplification Kit (Clontech 
Laboratories), as per manufacturer's instructions. The 
mismatched adaptors were prepared as following: a for-
ward primer 5’- end phosphorylated AdaptL (5’ PO4- 
TCGAGGGAATCTTGATATCGAATTCCTGC- 3’) and a 
reverse primer AdaptMS (5’- GCAGGAATTCGATATC
AAGCTTCCCTCGA −3’), where bold and italic letters 
indicated mismatched residues. These were synthesized 
by Sigma- Aldrich. 10  µl of both primers at concentra-
tion of 100  µM was mixed thoroughly, heated at 95ºC 
for 10 min in a water bath to anneal primers and cooled 
down gradually to form mismatched double- strand adap-
tors. This adaptor (200 pmol) was then ligated to the above 
double- strand cDNA using T4  ligase (Invitrogen). After 
dilution by 1 in 10 with H2O, the cDNA was used as PCR 
template to clone cDNA of 5’ end of FLT3, using forward 
primer, AP1 (5’- GCAGGAATTCGATATCAAGA- 3’), 
complementary to AdaptL and reverse primer FLT3- 
JHR3 (5’- CTGATGACTGAGAAAGTGTA- 3’), specific 
to chicken FLT3, with the following cycling conditions: 
94ºC for 1  min, 3 cycles of 53 ºC for 3  min, 3 cycles of 
94ºC for 1 min, 56 ºC for 1 min and 72 ºC for 1·5 min, 
and 30 cycles of 94ºC for 1  min, 58 ºC for 1  min and 
72 ºC for 1·5  min. Based on the DNA sequence of 
the FLT3 5’ end amplicon, a forward primer Flt3F1 
(5’ATCACCAGCATGGCAGTGTGTCT3’) was synthe-
sized, together with a reverse primer Flt3R1 (5’- GATAAC
ATCTTCTTAGTGGTGATGTGAA- 3’) to clone full- length 
chicken FLT3 cDNA from a splenic cDNA template, 
reversely transcribed from a 6- week- old J- line bird and 
following cycling conditions: 94ºC for 3 min, 33 cycles of 
94ºC 1 min 60ºC 1 min, 72ºC 3 min and then 72ºC 10 min, 
resulting in two amplicons, a full- length FLT3 (chFLT3) 
and a short isoform (chFLT3s).
Semi- quantitative RT- PCR analysis of 
FLT3 expression
Tissues (thymus, spleen, bursa of Fabricius, Harderian 
gland, caecal tonsil, Meckel's diverticulum, bone mar-
row, brain, breast muscle, heart, liver, kidney, lung, small 
intestine and testis) were dissected from 6- week- old 
J- line chickens. Total RNA was prepared from tissues 
using RNeasy mini kit (QIAGEN), following the manu-
facturer's instructions. 2 µg total RNA was then reverse- 
transcribed into cDNA, using Superscript III (Invitrogen) 
as per manufacturer's instructions. Primers Flt3- iosFwd 
5’- GCTCATCCAAATCAAACTGCT- 3’) and Flt3- iosRev 
5’- CAACTGACATGT TAATGAAGCTC- 3’) were used for 
PCRs to analyse FLT3 expression via following cycling 
conditions: 94ºC for 3 min, 33 cycles of 94ºC 1 min 55ºC 
30 sec, 72ºC 1 min. Chicken GAPDH was used as a control 
gene, as described before [35].
Expression and purification of 
recombinant chFLT3- Fc and recombinant 
chFLT3- V5HIS6 protein
The extracellular domains of chFLT3 or chFLT3s were 
sub- cloned into pKW06 to produce a fusion protein 
with a C- terminal human IgG1 Fc tag or pKW08 to pro-
duce a fusion protein with a V5HIS6 tag [36]. The con-
structs were named as pKW06/chFLT3, pKW06/chFLT3s, 
pKW08/chFLT3 and pKW08/chFLT3s. All constructs have 
their own signal peptides and were expressed in human 
embryonic kidney HEK293 cells as described elsewhere 
[37]. FLT3- Fc was purified using a HiTrap Protein G af-
finity column (GE Healthcare Life Sciences). The purity 
and identity of FLT3- Fc were confirmed by SDS- PAGE 
and analysis of tryptic peptides by mass spectrometry 
(Dr Dominic Kurian, Proteomics and Metabolomics, The 
Roslin Institute) before immunization.
Monoclonal antibody production, 
isotyping, purification and labelling
Mice were immunized with purified chFLT3- Fc fu-
sion protein. Immunization and cell fusion were car-
ried out by Dundee Cell Products (DCP, Dundee, UK). 
4 |   WU et al.
Following fusion, polyclonal hybridoma cultures were 
tested with recombinant chFLT3- V5HIS6 by dot- blot 
and six positive hybridoma cultures were selected by 
DCP. These samples were then further screened by 
ELISA with chFLT3- Fc, chFLT3- V5HIS6, Fc or V5HIS6 
controls and screened with chFLT3 transfected Ba/F3 
cells or control Ba/F3 cells (below). Positive samples 
were selected for further cloning to produce mono-
clonal hybridomas. Specificity of supernatant from 
monoclonal hybridoma cultures was again confirmed 
by ELISA and flow cytometry. Isotypes of these mono-
clonal antibodies were tested to common mouse an-
tibody isotypes (IgG1, IgG2a, IgG2b, IgG3, IgM and 
IgA) and to the κ and λ light chains using the IsoStrip 
Mouse Monoclonal Antibody Isotyping Kit (Roche). 
Monoclonal hybridomas were cultured in Dulbecco's 
modified Eagle's medium (DMEM) with 10% Ig- 
depleted foetal bovine serum (FBS). Monoclonal anti-
bodies were purified using HiTrap Protein G affinity 
columns (GE Healthcare Life Sciences) and dialysed 
against phosphate- buffered saline (PBS) using 30 kDa 
molecular weight cut- off (MWCO) Slide- A- Lyser cas-
settes (Pierce, Thermo Fisher Scientific). The con-
centrations of mAbs were determined by absorbance 
at 280  nm with a Nanodrop. Purified mAbs were la-
belled with Alexa Fluor™ 647 Antibody Labelling Kit 
(Invitrogen). All procedures were performed according 
to the manufacturer's instructions.
Transfection of Ba/F3 cell with full- length 
FLT3 for screening of hybridomas
The full length of chFLT3 or chFLT3s open reading frame 
(without stop codons) was cloned into the pEF6/V5- His 
TOPO expression vector (Thermo Fisher Scientific) in- 
frame with the V5 and His tags at the 3’ end of the pro-
tein. The pEF6- FLT3 or FLT3s expression constructs 
and pEF empty vector was transfected into Ba/F3 cells 
by electroporation and stably transfected Ba/F3 cells 
were selected with blasticidin as previously described 
for the chicken CSF1R gene [33]. Briefly, logarithmically 
growing Ba/F3 cells were harvested and resuspended in 
complete media at a concentration of 5 × 106 cells per 
200 µl. Cells were then placed in 0·4- cm electroporation 
cuvettes with 50 μl of PBS containing 5 μg plasmid DNA. 
The cuvettes were left to equilibrate at room tempera-
ture (RT) for 10  min before electroporation at 975 μF 
and 300 V using a Bio- Rad Gene Pulser electroporation 
apparatus. After electroporation, cells were washed in 
complete medium to remove surplus DNA, plated out in 
6- well plates and then incubated at 37 ºC for 24 h before 
adding 40 µg/ml blasticidin (Fisher Bioreagents, Fisher 
Scientific) for three weeks. Stable clones were selected 
for their survival in blasticidin.
Screening of hybridomas and 
confirmation of specificity by ELISA
Supernatant from hybridoma culture was screened by 
indirect ELISA as described previously [38]. Briefly, 
assay plates (Nunc Immuno MaxiSorp, Thermo Electron 
LED) were coated with recombinant FLT3- Fc, FLT3s- Fc, 
FLT3- V5H6, FLT3s- V5H6 or relative control protein in 
carbonate/bicarbonate buffer (15  mM sodium carbon-
ate, 35 mM sodium bicarbonate and 3 mM sodium azide; 
pH 9·6) and incubated overnight at 4 ºC. Plates were 
washed in PBS containing 0·1% (v/v) Tween 20 (PBS- T) 
and blocked with 0·5% (w/v) casein/PBS at RT for 1 h. 
Neat supernatant of hybridoma culture or purified mAb 
was added to the plate and incubated at RT for 1 h. After 
three washes with PBS- T, plates were incubated with 
goat anti- mouse IgG- horseradish peroxidase (HRP) at 
RT for 1 h. After a further three washes, plates were visu-
alized by 3,3’,5,5'- tetramethylbenzidine (TMB) substrate 
(Invitrogen, Thermo Fisher Scientific), and the reaction 
was stopped by 2N H2SO4. Plates were read at 450 nm in 
a SpectraMax 250 microplate spectrophotometer system 
(Molecular Devices, Sunnyvale, CA, USA).
Screening of hybridomas and 
confirmation of specificity with FLT3- Ba/
F3 cells
Parental Ba/F3 cells, stably transfected FLT3- Ba/F3, 
FLT3s- Ba/F3 or pEF- Ba/F3 were cultured in presence of 
IL- 3 (X63 medium). Cells were fixed with 1% (w/v) para-
formaldehyde in PBS, permeabilized with 0·1% saponin 
and stained with mouse anti- V5- Tag antibody (Bio- Rad) 
or IgG2a isotype control before adding goat anti- mouse 
IgG- fluorescein isothiocyanate (FITC; Bio- Rad) for flow 
cytometric analysis. To detect surface FLT3, cells were 
incubated with supernatant from hybridoma culture or 
purified mAbs on ice for 30 min before adding goat anti- 
mouse IgG (H  +  L) cross- adsorbed secondary antibody, 
conjugated with Alexa Fluor 647 (Invitrogen, Thermo 
Fisher Scientific) to detect hybridoma supernatant and 
then analysed by flow cytometric analysis.
Development of specific reagent to XCR1
The protein sequence of chicken XCL1 was obtained 
from NCBI (Accession NP_990377). The mature 
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peptide of chicken XCL1 (previously known as lym-
photactin), with the addition of a terminal lysine 
residue for coupling, was synthesized (Sequence: 
S V A S Q S M R K L S C V N L S T Q K V D I R S I V N Y E K Q K 
V P V E A V M F I T A N G I R I C V H P E Q K W V Q S A 
MKRIDRRRTTRRRK) and coupled with Alexa Fluor 
647 (Linker- Cys- AF647; ALMAC Science (Edinburgh, 
Scotland)), yielding reagent XCL1AF647. The cDNA se-
quence for chicken XCR1 was obtained from NCBI 
(Accession NM_001045838). To analyse the specificity of 
the reagent, the full length of XCR1 open reading frame 
(without stop codon) was cloned into the pEF6/V5- His 
TOPO expression vector (Thermo Fisher Scientific) in- 
frame with the V5 and His tags at the 3’ end of the protein. 
The pEF- XCR1 plasmids were transfected into Ba/F3 cells 
and selected with blasticidin to produce stably transfected 
Ba/F3 (XCR1- Ba/F3) as described above for the transfec-
tion of Ba/F3 cells with full- length FLT3 for screening of 
hybridomas. XCR1- Ba/F3 or pEF- Ba/F3 transfected cells 
were then harvested and stained with XCL1AF647 (0·2 μg/
ml) on ice for 30 min. Human IgG1- Fc was conjugated to 
Alexa Fluor 647 using the AF647 Microscale Protein label-
ling kit (Thermo Fisher Scientific) according to manufac-
turer's instructions to use as peptide control. Cells were 
then washed twice with FACS buffer (PBS, 1·0% (w/v) 
bovine serum albumin and 0·05% (w/v/) sodium azide) 
and resuspended in FACS buffer with SYTOX® Blue 
(Invitrogen; 1 mM solution in dimethylsulphoxide; 1/4000 
dilution) immediately prior to flow cytometric analy-
sis using a LSRFortessa (Becton Dickinson). Resulting 
data were analysed using FlowJo V10 software (FlowJo, 
Ashlan, OR. USA).
Development of labelled CSF2 to detect 
CSF2R expression
Chicken CSF2 (GM- CSF) cDNA [39] was sub- cloned into 
the vector pKW06 to produce recombinant protein with 
a C- terminal human IgG1 Fc tag (CSF2- Fc) as described 
previously [36]. CSF2- Fc specifically binds to chicken 
CSF2R on the surface of chicken granulocytes and mono-
cytes and macrophages (Wu et al., manuscript in prepara-
tion). CSF2- Fc was conjugated to Alexa Fluor 647 using 
the AF647  Microscale Protein labelling kit (Molecular 
Probes, Thermo Fisher Scientific) according to the manu-
facturer's instructions. CSF2- Fc was also recognized with 
goat F(ab’) anti- human IgG- phycoerythrin (PE) (mouse 
absorbed, Cambridge BioScience) as in Table 1 when co- 
staining with XCL1AF647.
Chicken splenic white blood cells (splenocytes) were 
isolated from CSF1R- eGFP reporter transgenic birds aged 
from 3– 20  weeks and age- matched Hy- line wild- type 
controls. Briefly, the spleen was removed, cut into small 
pieces and homogenized using a borosilicate glass homog-
enizer (Fisher Scientific UK Ltd) with ice- cold dissection 
medium (calcium- and magnesium- free Hank's balanced 
salt solution (HBSS) with 10mM HEPES 0·45% (w/v) glu-
cose and 1mM sodium pyruvate) and filtered through a 
100- µm cell strainer into a 50- ml tube. Homogenized solu-
tion for birds older than 3 weeks of age was overlaid on 
Histopaque- 1·077 (Sigma- Aldrich) and spun at 400 g for 
20 min at RT with the brake off. Cells at the density in-
terface were collected, washed, resuspended in cold FACS 
buffer and placed on ice for 10 min. Cold cells were then 
stained with a combination of mAbs as in Table 1 in FACS 
buffer for 30 min on ice in the dark. Cells were then washed 
three times, resuspended in cold FACS buffer and stained 
with SYTOX® Blue Dead Cell Stain (Invitrogen; 1·0  mM 
stock, 1/4000 dilution) for live cell gating. Data were col-
lected with a LRSFortessa (BD Biosciences) and analysed 
using FlowJo V10 software. At least 100,000 events were 
acquired. Dead cells were excluded by SYTOX® Blue stain-
ing and doublets were then discriminated based on signal 
processing (FSC- A/H). Fluorescence minus one controls 
(FMO) were used to confirm gating strategies. The di-
mensionality reduction algorithm, t- distributed stochastic 
neighbour embedding (t- SNE) was used to generate cell 
clusters.
Culture of chicken BM- derived 
dendritic cells
Chicken bone marrow cells were isolated from two- week- 
old CSF1R- eGFP transgenic chickens (n = 3) and cultured 
with CSF2 and IL- 4 for 7 days as described previously [40]. 
Chicken BMDCs were collected by pipetting, washed with 
cold FACS buffer and stained with XCL1AF647, anti- FLT3 
and KUL01- RPE for 30 min in FACS buffer on ice. Goat 
anti- mouse IgG1 was used as secondary antibody to detect 
anti- FLT3. All staining was carried out on ice and washes 
performed with ice- cold buffer. Data were collected with a 
LRSFortessa (BD Biosciences) and analysed using FlowJo 
V10 software.
In vitro staining of splenic dendritic 
cells and confocal imaging
Splenocytes were prepared as described above from 
12- week- old CSF1R- eGFP reporter transgenic birds. 
0·2  ×  106 cells were plated on fibronectin- coated 8- 
well Nunc Lab- Tek II Chamber slides (Thermo Fisher 
Scientific) and incubated at 41˚C with RPMI medium sup-
plemented with 10% (v/v) heat- inactivated FBS, 2  mM 
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L- glutamine and antibiotics (100 g/ml penicillin, 100 g/ml 
streptomycin) for one hour. After one- hour, non- adherent 
cells were gently washed off with RPMI and remain-
ing adherent cells were incubated overnight in complete 
RPMI medium supplemented with 200  ng/ml recombi-
nant chicken CSF1 produced as described previously [30]. 
The next day slides were chilled on ice for 30 minutes and 
stained using XCL1AF647, anti- chicken MHCII- RPE and 
KUL01- RPE (Table 1) in RPMI. After one hour, cells were 
washed in phenol red- free RMPI medium. After staining, 
phenol red- free RMPI with 10% (v/v) FBS was added to 
the cells and the chamber slides were placed on a micro-
scope stage heated to 41˚C and imaged using a Zeiss LSM 
710- inverted microscope.
Immunofluorescent 
staining of FLT3+ cells and confocal 
imaging of tissue sections
Unfixed tissue sections from four- week- old birds were 
embedded in Cellpath™ OCT Embedding Matrix (Fisher 
Scientific UK Ltd, Loughborough, UK) and snap- frozen 
at −80˚C for two hours. 10- µm sections were cut onto 
Superfrost Plus slides (Menzel- Gläser, Braunschweig, 
Germany), air- dried for one hour at room temperature 
before being fixed with 100% methanol at 4°C for 10 min 
and then air- dried for a further one hour at room tem-
perature. All primary antibodies used in this study are 
shown in Table 1. All slides were blocked for one hour 
in 2·5% skimmed milk powder (Oxoid Ltd., Basingstoke, 
UK), 2·5% normal horse serum (Sigma, Gillingham, 
UK), 0·1% Triton X- 100 (Sigma, Gillingham, UK) in PBS 
(MST- PBS). Isotype- matched antibody controls (Table 
1) were added at the same concentration as primary 
antibodies. Primary antibodies: goat anti- chicken IgY 
(H + L), Alexa Fluor 488 (Thermo Fisher Scientific (Life 
Technologies Ltd.), Renfrew, UK) used at 1/500 dilu-
tion; all other antibodies used at 1/100 dilution. All pri-
mary antibodies diluted in blocking reagent (above) and 
incubated at 4°C overnight, washed for 20  minutes in 
PBS, followed by incubation with secondary antibodies 
for two hours (donkey anti- mouse IgG Alexa Fluor 594, 
donkey anti- mouse IgG1 Alexa Fluor 594, donkey anti- 
mouse IgG2a Alexa Fluor 647; Thermo Fisher Scientific 
(Life Technologies Ltd.)) used at 1/300 dilution and 
mounted in ProLong® Gold Antifade Mountant (Thermo 
Fisher Scientific (Life Technologies Ltd.)). Where ap-
propriate, sections were counterstained with 1 μg/ml 4′, 
6′- diamidino- 2- phenylindole (DAPI; Sigma, Gillingham, 
UK) in the final incubation step. Samples were imaged 
using an inverted confocal microscope (Zeiss LSM710) 
and images analyses using Zeiss ZEN 3·1 software.
Preparation of bacteria and 
phagocytosis assay
Salmonella enterica serovar Typhimurium strain ST4/74 
nalR and an isogenic mutant lacking the function of type 
III secretion system 1(ΔprgH) which promotes bacterial 
invasion were used in this study [32]. Both ST4/74 nalR 
and ST4/74 nalR ΔprgH were engineered to constitu-
tively express mCherry by transformation with a deriva-
tive of pFVP25·1 [41] (Salmonella- mCherry). Bacteria 
were streaked from frozen glycerol stocks onto fresh 
Luria Bertani (LB) agar plates and incubated at 37°C 
overnight. A single bacterial colony was inoculated into 
LB broth and incubated in a shaking incubator over-
night at 37°C. Optical density at 600 nm (O.D.600) of the 
overnight culture was measured to determine the bac-
terial count, and the culture was diluted in RPMI 1640 
(Gibco, Thermo Fisher Scientific) with 10% (v/v) FBS to 
achieve the desired multiplicity of infection (MOI). The 
bacterial viability and the MOI were retrospectively de-
termined by plating of serial ten- fold culture dilutions 
to agar medium.
Single- cell suspensions of splenocytes from 
11- week- old CSF1R- eGFP transgenic reporter birds [10] 
were isolated as described above, washed with RPMI1620 
twice, resuspended in RPMI1640 with 10% (v/c) FBS 
and plated into a 96- well U- bottom plate. The above two 
stains of Salmonella- mCherry were added at a MOI of 
5 for 45 min at 41 °C. A duplicated plate with cells was 
pre- chilled, and the same number of bacteria was added 
and left on ice for controls. Cells were then washed and 
incubated with RPMI with 10% (v/v) FBS containing 
100  μg/ml gentamicin (Thermo Fisher Scientific) for 
30 min to kill extracellular Salmonella. Then, the cells 
were washed with cold PBS, stained with FLT3  mAb 
and analysed by flow cytometry as described above. Two 
independent phagocytosis assays were performed, and 
six CSF1R- eGFP birds and two Hy- Line wild- type birds 
(flow control) were used in total. Results are presented 
as the relative percentage of mCherry- expressing cells in 
each population (the mean ±standard deviation (SD)). 
Geometric mean fluorescence intensity (MFI) was 
used to measure the expression level of mCherry. The 
integrated mean fluorescence intensity (iMFI) [42,43] 
was introduced to reflect the total functional response 
of mCherry+ cells. iMFI is computed by multiplying 
the relative frequency (% positive) of cells expressing 
mCherry with MFI of mCherry+ population.
Statistical analysis was conducted using a two- tailed 
unpaired t- test with Welch correction. Statistical signif-
icance was defined as follows: ∗, p < 0·05; ∗∗, p < 0·01; 
and ∗∗∗, p < 0·001. All analyses were performed using the 
statistical program PRISM 7 (GraphPad).
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RESULTS
Chicken FLT3 gene and isoforms
The only chicken FLT3 transcript annotated in ENSEMBL 
(ENSGALT00000080989·3) encodes an 877 amino acid 
predicted protein, truncated at the N terminus relative 
to orthologs in turkey and zebrafinch. Using 5’ rapid am-
plification of cDNA ends (RACE) method, we amplified 
an extended cDNA product of approximately 460 base 
pairs (bps) in length, that contained a short- length of 5’ 
untranslated region, a start codon and a signal peptide 
region of chicken FLT3 (chFLT3), which corrected the 
prediction in the ENSEMBL database for a signal peptide 
region of chFLT3. Based on this information, we cloned 
full- length of FLT3 cDNA. The largest open reading frame 
of chFLT3 is 2,988 bps and composed of 24 coding exons. 
The predicted protein sequence of chFLT3 has 50·5% and 
51·6% identity with human and murine FLT3, respec-
tively. ChFLT3 gene encodes 995 amino acids, including 
a signal peptide region (aa 1– 19), an extracellular domain 
(aa 20– 548), a transmembrane domain (aa 549– 569) and 
an intracellular domain (aa 570– 995), which contains a 
tyrosine- kinase domain consisting of 2  lobes joined by a 
tyrosine- kinase insert and a C terminus (Figure 1). In our 
PCR cloning, we also identified an isoform of chFLT3 with 
a deletion mutation, named as chFLT3s. The chFLT3s is 
219 bps shorter than chFLT3, with a deletion of 107 bps in 
3’ end of exon 9 and 112 bps in 5’ end of exon 10, resulting 
in a 73- aa deletion located at the N terminal end of the ex-
tracellular domain in comparison with chFLT3 (Figure 1).
Tissue distribution and cellular 
expression of chicken FLT3
The expression patterns of chFLT3 isoforms were analysed 
by RT- PCR using Flt3- iosFwd/iosRev primers. In contrast 
to rather restricted expression of human and murine FLT3 
(see www.biogps.com), chFLT3 was widely expressed at 
the mRNA level in lymphoid and most non- lymphoid tis-
sues analysed apart from brain, muscle and heart. ChFLT3 
was a predominant isoform, whereas chFLT3s was only 
weakly expressed (Figure 2). The widespread expression is 
confirmed in a large- scale meta- analysis of gene expression 
data to produce a chicken gene expression atlas [44].
Generation of mouse anti- 
chFLT3 monoclonal antibodies
To generate monoclonal antibodies recognizing chicken 
FLT3, mice were immunized with FLT3- Fc and hybrid-
omas generated as described in Methods and Materials. 
After initial screening, six hybridoma supernatants were 
further screened by ELISA (Figure S1A). Three produced 
antibodies that bound specifically to FLT3- Fc and FLT3- 
V5H6, but not FLT3s- Fc or FLT3s- V5H6, Fc or V5H6 con-
trols. To enable studies of the binding specificity of mAb to 
FLT3, Ba/F3 cells were stably transfected with full- length 
FLT3 or FLT3s. The success of transfection was tested by 
intracellular staining against the V5 tag. Anti- V5  stain-
ing (Figure S1B) showed around 36% of Ba/F3 cells were 
successfully transfected for chFLT3 or chFLT3s. Two hy-
bridoma supernatants (4E7 and 8A5) among the three 
tested were found to bind Ba/F3 cells stably transfected 
with full- length FLT3 (FLT3- Ba/F3), but not the short 
form (FLT3s- Ba/F3) or empty pEF6 vector transfected Ba/
F3 cells (pEF- Ba/F3). All three hybridomas selected by ei-
ther ELISA or flow cytometry analysis were further cloned 
to produce monoclonal hybridomas. Unfortunately, 
8A5  stopped producing antibody after sub- cloning. 4E7 
and 8D12 were isotyped and found to be IgG1. These two 
monoclonal hybridomas were designated as ROS- AV184 
(4E7) and ROS- AV185 (8D12) for future reference.
Confirmation of the 
specificity and utility of the anti- 
chFLT3 monoclonal antibody
Monoclonal antibodies ROS- AV184 and ROS- AV185 were 
purified and further tested by ELISA and flow cytom-
etry analysis on Ba/F3 cells (Figure 3). Both ROS- AV184 
and ROS- AV185  specifically recognized FLT3 by ELISA 
(Figure 3a). As in the screening, ROS- AV184 recognized 
FLT3- Ba/F3, but not FLT3s- Ba/F3 or pEF- Ba/F3 control 
cells. ROS- AV185 failed to stain transfected Ba/F3 cells 
(Figure 3b). Henceforward, ROS- AV184 (4E7) was used as 
mouse anti- chicken FLT3 as listed in Table 1. Anti- chFLT3 
was used to detect FLT3+ cells in situ by immunofluores-
cence staining. Anti- chFLT3 did not detect specific cell 
populations in paraformaldehyde- fixed or acetone- fixed 
tissues (data not shown). In methanol fixed sections, 
F I G U R E  1  Alignment of the predicted chicken fms- like tyrosine- kinase 3 (chFLT3) amino acid (aa) sequence with those of human 
(P36888- 2) and mouse (Q3UEW6) Flt3, with reference to secondary structural features. Shaded areas represent conservation of amino acid 
similarity— the darker the shading, the more conserved the residue across species. Dashes indicate gaps in the alignment. Empty reverse 
triangles above the sequences indicate the start points of each domain, and filled diamonds label the start points of each substructure of 
intracellular domain. TM: transmembrane domain, JM: juxtamembrane domain, TK1: tyrosine- kinase 1 domain, KI: tyrosine- kinase insert 
domain, TK2: tyrosine- kinase 2 domain, CT: C terminus. Filled triangles indicate that those residues are lack in chFLT3s isoform
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anti- chFLT3  stained ramified MHCII+ cells in the liver 
(Figure 3c; Figure S2A- D). Liver FLT3+ cells were scattered 
throughout the parenchyma and concentrated around 
blood vessels (Figure 3c; Figure S2A- D). In contrast, 
MRC1L- B+ MHCII+ liver macrophages and Kupffer cells 
[27] were more abundant in the liver parenchyma and not 
concentrated around blood vessels (Figure 3c; Figure S2C). 
In the bursa of Fabricius FLT3+ MHCII+ cell were located 
in the interfollicular regions, but not with B- cell follicles 
(Figure 3c; Figure S2E,F). In the spleen, FLT3+ MHCII+ 
cells were abundant in the red pulp but not detected in the 
periellipsoid white pulp (PWP), nor germinal centres (GC) 
(Figure 3d; Figure S3A, B). Anti- chFLT3 also stained the 
MHCII− ellipsoid blood vessels, but not other blood vessels 
(including the central artery; Figure 3d; Figure S3Ci, Cii).
Identification of splenic conventional 
dendritic cells using the anti- 
chFLT3 monoclonal antibody ROS- AV184
In mammals, FLT3 is highly expressed on haematopoietic 
progenitor cells and is progressively lost in cells committing 
to the B cell, T cell, granulocyte/macrophage and megakar-
yocyte/erythrocyte lineages [12,14,45], whereas expression 
is maintained in the dendritic cell lineages [46]). In RNA 
expression analysis, chicken cDCs but not macrophages, T 
cells nor B cells were found to express FLT326. Most if not 
all DC in mouse also express CSF1R mRNA, albeit at the 
lowest levels in cDC1s, and in non- lymphoid tissues are 
CSF1R- dependent [47]. In the current study, anti- chFLT3 
was used to stain cell surface FLT3 in chicken splenocytes. 
Figure 4a shows that high levels of FLT3 were detected 
in a subpopulation of CD45+ cells in both wild- type (WT) 
and CSF1R- eGFP transgenic birds. The majority (~80%) of 
FLT3HI CD45+ cells expressed the CSF1R- eGFP transgene 
(Figure 4a,b). Staining for cell lineage markers Bu- 1(B 
cells), CD3 (T cells) or MRC1L- B (macrophages) was not 
observed in FLT3HI cells, irrespective of CSF1R- transgene 
expression (Figure 4c). FLT3HI cells expressed high levels 
of MHCII, consistent with immune- fluorescence stain-
ing of tissues (Figure 3c,d). In the CSF1R- eGFP− popula-
tion, FLT3 was expressed at low- to- intermediate levels, 
(Figure S4). CSF1R- eGFP− FLT3INT cells did not consist 
of a discrete cell population in our analysis, with CSF1R- 
eGFP− FLT3INT cells expressing variable levels of MHCII, 
MRC1L- B, CD3 and Bu- 1 (Figure S4).
We then gated on CSF1R- eGFP+ cells and further seg-
regated these cells into three populations based on FLT3 
expression levels (FLT3HI, FLT3LOW and FLT3− popu-
lations, Figure 4d,e,f). The CSF1R- eGFP+ FLT3HI and 
FLT3LOW populations showed significantly lower levels of 
CSF1R- transgene expression than the FLT3− population 
(Figure 4e). The geometric mean fluorescent intensity 
(MFI) of CSF1R- eGFP expression was significantly dif-
ferent between the FLT3HI or FLT3LOW populations and 
F I G U R E  2  Tissue expression of chFLT3 isoforms. Tissues were dissected from a 6- week- old male J line, including lymphoid and 
non- lymphoid chicken tissues, where HG refers to Harderian gland; CT, caecal tonsil; Meckel's, Meckel's diverticulum; BM, bone marrow. 


















































F I G U R E  3  Confirmation of the specificity of purified monoclonal antibodies for FLT3 by ELISA (a) and flow cytometric analysis on 
transfected Ba/F3 cells (b). Plates were coated with chFLT3 or control protein. Purified antibodies ROS- AV184 (4E7) and ROS- AV185 (8A5) 
effectively recognized chFLT3 not control proteins by ELISA (a). Purified ROS- AV184 (4E7) specially labelled FLT3- Ba/F3 not FLT3s- Ba/
F3 or control Ba/F3 (b). Y- axis = FSC- H; purified mAbs or IgG1 isotype control as detected by secondary goat anti- mouse IgG1- AF647. (c 
and d). Confocal analysis of anti- FLT3 (ROS- AV184) staining on sections of liver, bursa and spleen. Co- staining of anti- FLT3 and MHC 
II on liver sections revealed that liver FLT3+ cells were scattered throughout the parenchyma and concentrated around blood vessels 
(yellow arrows); scale bar = 20 µm. In contrast, MRC1L- B+ MHCII+ liver macrophages and Kupffer cells were more abundant in the liver 
parenchyma and not concentrated around blood vessels (yellow arrows); scale bar = 20 µm. Co- staining of anti- FLT3 and MHC II in the 
bursa of Fabricius revealed that FLT3+ MHCII+ cell were located in the interfollicular regions (red arrow), but not with B- cell follicles 
(labelled as F); Scale bar =20 µm. Co- staining of anti- FLT3 and MHC II on the spleen sections demonstrated that FLT3+ MHCII+ cells were 
abundant in the red pulp but not detected in the periellipsoid white pulp (PWP), nor germinal centres (GC). Anti- chFLT3 also stained the 
MHCII− ellipsoid blood vessels (penicillary capillaries, PC), but not other blood vessels (including the central artery, CA); scale bar = 50 µm
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FLT3− population (Figure 4e). The MFI of CSF1R- eGFP 
expression of the FLT3HI population was also marginally 
lower than the FLT3LOW population (Figure 4e). The FLT3HI 
population was CD45+ Bu- 1− CD3− MRC1L- B− MHCIIHI. 
Two MRC1L- B+ populations were identified. The FLT3LOW 
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identified as a chicken splenic macrophage subpopulation 
[48], whereas the FLT3− MRC1L- B+ MHCII+ cells repre-
sent ‘classical’ chicken splenic macrophages [49].
Development of specific reagent to XCR1
The chemokine XCL1 is the sole ligand for XCR1, which has 
been reported to be a highly specific functional marker for 
the cDC1  subset in mammals [47,49- 51]. Transcriptional 
analysis of chicken MPS cells indicated that XCR1 is 
co- expressed with other genes associated with the mam-
malian cDC1  subset (including FLT3, CIITA, ZBTB46, 
ID2, IRF8, CADM1) in the spleen, liver and lungs [26- 28]. 
Therefore, we investigated whether XCR1 had similar DC- 
associated expression in chickens. The unique structure of 
chemokine receptors which have seven transmembrane 
spanning domains make production of monoclonal anti-
bodies to XCR1 non- trivial. As an alternative approach, 
receptor detection using fluorescent ligands has been de-
veloped and widely used for detection of chemokine re-
ceptors using flow cytometry [52- 55]. The relatively small 
F I G U R E  4  Identification of splenic cDC using the anti- chFLT3 monoclonal antibody (ROS- AV184) by flow cytometric analysis. (a) 
Identification of FLT3HICD45+ population in splenocytes from 3 weeks old Hy- line wild- type (WT) or CSF1R- eGFP transgenic birds. Single, 
live and CD45+ cells were gated for the analysis. FLT3HICD45+ cells were identified and coloured in red. The relative percentages of FLT3HI in 
CD45+ populations between two lines of birds were compared. (b) The statue of CSF1R- eGFP expression on FLT3HICD45+ cells. FLT3HICD45+ 
cells were gated as FLT3HICSF1R- eGFP−/LOW and FLT3HICSF1R- eGFP+ in histogram based on their expression levels of CSF1R- eGFP and 
overlaid in dot plot to show both populations (FLT3HICSF1R- eGFP−/LOW in purple and FLT3HICSF1R- eGFP+ in red). The percentages of 
FLT3HICSF1R- eGFP−/LOW and FLT3HICSF1R- eGFP+ are shown on the left. (c) Phenotypes of splenic FLT3HI population in terms of CSF1R- 
eGFP, BU- 1, CD3, MRC1L- B and MHC II as determined by co- staining of anti- FLT3 with anti- BU- 1, anti- CD3, KUL01 or anti- MHCII. (d) 
CSF1R- eGFP+ cells were gated and further separated into three populations based on their expression levels of FLT3. Black, isotype control 
of CSF1R- eGFP+ cells; red, FLT3HI population; green, FLT3LOW population; blue, FLT3− population. (e) MFI of CSF1R- eGFP expression 
across the above three populations. (f) Expression of CD45, BU- 1, CD3, MRC1L- B and MHCII on CSF1R- eGFP+ FLT3HI, FLT3LOW and 
FLT3− populations. Top, coloured dot plot showing overlays of the three populations; bottom, histogram showing the phenotypes of the three 
populations. Black, isotype controls. Representative plots from one of three animals. Data were analysed using two- tailed unpaired t- test with 
Welch correction. Data are presented as mean ±SD of three birds
F I G U R E  5  XCLAF647 specifically binds to XCR1- Ba/F3 and dead cells. Ba/F3 cells transfected with XCR1 or pEF control plasmids were 
labelled with XCLAF647 or control peptideAF647 and gated into live/dead cells based on SYTOX® Blue staining profiles. XCL1AF647 was found to 
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size of XCL1 enables it to be produced by total peptide 
synthesis and we used this approach to generate a deriva-
tive conjugated to Alexa Fluor 647 (XCL1AF647). XCL1AF647 
was first shown to bind specifically to Ba/F3 cells stably 
transfected with XCR1 (Figure 5). In mammals, XCR1+ 
DCs are superior to other DC subsets in internalizing dead 
or dying cells [56], consistent with their role in the cross- 
presentation of antigen to CD8+ T cells [50,55- 58]. Binding 
studies suggested that XCL1  marked stressed and dead 
cells for uptake into cross- presenting DCs [59]. Similarly, 
chicken XCL1AF647 also bound to dead cells irrespective of 
XCR1 (Figure 5) expression, further strengthening support 
for a role of XCL1 in the recognition and uptake of dead 
cells (or their derivatives) by XCR1+ cDCs.
The chemokine receptor XCR1 is 
selectively expressed on chicken 
FLT3HI cDCs
To investigate whether chicken XCR1 expression is con-
served on the surface of chicken cDCs, we analysed XCR1 
expression in splenic cells using the newly developed 
reagent XCL1AF647 in combination with staining for FLT3 
(Figure 6). Co- staining of FLT3 and XCR1 on live splenic 
cells was from CSF1R- eGFP transgenic chickens were 
visualized using t- SNE [60]. XCR1 staining was restricted 
to the FLT3HI cell population (Figure 6a- c). ~80% of 
FLT3HI XCR1+ cells expressed the CSF1R- eGFP transgene 
(Figure 6d,e). The FLT3HI XCR1+ population, regardless 
of CSF1R- eGFP status, did not express MRC1L- B (Figure 
6f). Based on co- expression of FLT3 and XCR1, we desig-
nated the FLT3HI XCR1+ subset as chicken cDCs.
Chicken cDC have a distinct cell 
surface phenotype compared to 
mammalian orthologues
To further characterize the cell surface phenotype of chicken 
cDC and macrophage populations, the expression profiles of 
CSF1R [31], CSF2R or TIM4 [27] were analysed (Figure 7). 
CSF1R- dependent signalling controls macrophage differ-
entiation and survival. In mammals, CSF1R is not detected 
[2,61- 63] or weakly detected [47] in the XCR1+ cDC1 sub-
set. In contrast, chicken XCR1+ cDCs showed expression 
F I G U R E  6  XCR1 is selectively expressed on FLT3HI cDC. Splenocytes were isolated from 3- week- old CSF1R- eGFP transgenic chickens 
and stained for XCR1 and FLT3. (a) tSNE visualization of all live cells. tSNE plots were generated based on the SSC- A, FSC- A, CSF1R- eGFP, 
FLT3 and XCR1 staining. (b) Cell clusters were backgated on SSC/FSC plot to confirm the size and granularity of different populations 
and to identify heterophils. (c) Cell clusters were backgated on XCR1/FLT3 plot to confirm their identities. Yellow = heterophils; 
red = FLT3HIXCR1+ cDC; blue = CSF1R- eGFP+FLT3−XCR1− macrophages; green = CSF1R- eGFP+FLT3LOWXCR1− population. (d) The 
FLT3HIXCR1+ cDC cluster was gated into CSF1R- eGFP−/LOW and CSF1R- eGFP+ populations based on their expression levels of CSF1R- 
eGFP and backgated on to the tSNE plot. Purple = FLT3HIXCR1+CSF1R- eGFP− population; red = FLT3HIXCR1+CSF1R- eGFP+. (e) The 
percentages of FLT3HIXCR1+CSF1R- eGFP− population and FLT3HIXCR1+CSF1R- eGFP+ populations (n = 3). (f) Histogram showing the 
expression levels of macrophage marker MRC1L- B on the surface of FLT3HIXCR1+CSF1R- GFP− (purple) and FLT3HIXCR1+CSF1R- eGFP+ 


















































































   | 15REAGENTS TO IDENTIFY CDCS IN THE CHICKEN
of the CSF1R (Figure 7a), as detected by staining with 
anti- CSF1R mAb [31], albeit at lower levels compared with 
XCR1− CSF1R- eGFP+ macrophages (Figure 7a). There was 
no difference in the level of CSF1R staining between CSF1R- 
eGFP− and CSF1R- eGFP+ cells (Figure 7a).
TIM4 is cell surface receptor for apoptotic cells [27]. 
XCR1+ cDCs expressed TIM4 at an intermediate level com-
pared with other CSF1R- eGFP+ populations, irrespective of 
CSF1R- eGFP expression (Figure 7b). As in Figure 4, all three 
populations expressed high level of MHCII. These data sug-
gest that all three populations are potential APCs, whereas 
TIM4- dependent recognition of apoptotic cells is restricted 
to FLT3HI cDCs and a subset of splenic macrophages [27].
Granulocyte- macrophage colony- stimulating factor 
(GM- CSF, CSF2) is a growth factor that controls the differen-
tiation of the haematopoietic progenitors [64]. In mammals, 
GM- CSF controls terminal differentiation of XCR1+ cDCs 
[65] and non- lymphoid tissue dendritic cell homeostasis 
F I G U R E  7  Cell surface phenotype of splenic cDC. Cell surface expression of CSF1R (a) or TIM4 (b) by splenic cDC. Splenocytes from 
20- week- old CSF1R- eGFP birds were isolated and stained with XCL1AF647 with anti- CSF1R mAb or anti- TIM4 as in Table 1. tSNE plots of all 
single live cells were generated based on the SSC- A, FSC- A, CSF1R- eGFP, XCR1 and CSF1R or TIM4 staining. Separated cell clusters were 
backgated to identify cDC and macrophage populations. Red = CSF1R- eGFP+XCR1+ cDC; purple = CSF1R- eGFP−XCR1+ cDC; blue = CSF1R- 
eGFP+ XCR1− macrophages; black = isotype controls in histogram. (c) Cell surface expression of CSF2R by splenic cDC. Splenocytes from 
3- week- old CSF1R- eGFP+ birds were isolated and stained with anti- FLT3 mAb with CSF2- Fc. tSNE plots of CSF1R- eGFP+ cells were generated 
based on the SSC- A, FSC- A, FLT3 and CSF2R staining. Separated cell clusters were backgated to confirm the phenotype of splenic cDC and 
macrophage populations. Red = CSF1R- eGFP+FLT3HICSF2R− cDC; blue = CSF1R- eGFP+FLT3−CSF2R+ macrophages; green = CSF1R- 
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[66]. The CSF2 receptor (CSF2R, also known as GM- CSFR) 
is a heterodimer composed of the beta common chain (also 
shared with the receptors for IL- 3 and IL- 5) and the CSF2- 
specific alpha chain (CSF2RA) [67,68]. The chicken genome 
contains three CSF2RA paralogues, and it remains unclear 
in which paralogue represents the bona fide CSF2RA [27]. 
In the absence of specific antibodies to the different chicken 
CSF2RA paralogues, we used a strategy previously used to 
characterize functional CSF2R expressing cells in murine 
studies [69] and our own studies with chicken CSF1 [30]. 
A novel avian reagent for labelling the chicken CSF2R 
was created by fluorescently tagging a recombinant chi-
meric protein containing chicken CSF2 coupled to human 
Fc of IgG1. This CSF2- Fc reagent labels a large number of 
cell types in the spleen, including granulocytes (data not 
shown). To better visualize MPS populations, tSNE analysis 
was performed on CSF1R- eGFP+ cells (Figure 7c). Chicken 
cDCs (CSF1R- eGFP+ FLT3HI cells) lacked the expression of 
CSF2R whereas FLT3LOW and FLT3− macrophage subsets 
were clearly labelled with the CSF2- Fc reagent (Figure 7c).
Cultured chicken BMDCs do not 
phenotypically represent in vivo cDCs
Bone marrow (BM) cells cultured in CSF2 and IL- 4 have 
APC activity and have been referred to as BM- derived DC 
(BMDC) [70,71]. To determine whether chicken BMDCs 
are representative of in vivo XCR1+ FLT3HI cDCs, chicken 
BMDCs were cultured as previously described [40] and the 
cell surface phenotypes were investigated using the newly 
developed reagents. The cultured BMDCs were heteroge-
neous populations but mostly large cells with two levels of 
CSF1R- eGFP expression (Figure 8a). Both CSF1R- eGFPHI 
and CSF1R- eGFPLOW populations expressed MRC1L- B, 
but neither had detectable XCR1 or FLT3 (Figure 8b,c). 
In chickens, bone marrow- derived macrophages grown in 
CSF1 also express high levels of MHCII, but did not ex-
press detectable FLT3 or XCR1 mRNA [72].
Appearance of chicken cDCs
The term ‘dendritic cell’ was originally coined to describe 
an adherent cell type, isolated from murine lymphoid or-
gans, which could be differentiated from macrophages on 
the basis of a tree like (i.e. ‘dendritic’) morphology and 
lack of endocytic function [73]. We compared the mor-
phology of chicken cDCs and macrophages in adherent 
cell cultures from the spleens of CSF1R- eGFP transgenic 
chickens to determine whether these cell types could be 
distinguished morphologically from each other. To avoid 
fixation dependent changes to cDC morphology, we per-
formed confocal microscopic analysis of live cells. Two 
F I G U R E  8  Flow cytometric analysis 
of surface expression of XCR1, FLT3 
and MRC1L- B (red) on BMDC. Relative 
FMO are shown as controls (black). 
Representative data from three birds. 
(a) Live, big and CSF1R- eGFP+ cells 
(low and high as shown in red) were 
gated for analysis. CSF1R- eGFPLOW and 
CSF1R- eGFPHI populations were shown. 
(b) Dot plot shows that both CSF1R- 
eGFPHI and CSF1R- eGFPLOW cells did not 
express XCR1 and FLT3 but expressed 
MRC1L- B. (c) Histograms for XCR1, FLT3 
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main cell morphologies of adherent splenic cells were 
observed, rounded cells with ruffled edges and many in-
tracellular vacuoles and elongated cells with dendritic 
projections that lacked ruffled edges and obvious intra-
cellular vacuoles. The former population consisted of 
MRC1L- B+ macrophages (Figure 9a), whereas the latter 
comprised of XCR1+ cDCs (Figure 9c). Consistent with 
previous data, labelled MRC1L- B was rapidly internal-
ized by macrophages [29]. Macrophages also internalized 
MHCII under these conditions, whereas MHCII stain-
ing on XCR1+ cDCs largely remained confined to the cell 
plasma membrane (Figure 9b).
Salmonella Typhimurium interactions 
with cDCs
Salmonella enterica serovars that are frequently isolated 
from chickens, such as Typhimurium and Enteritidis, 
also infect humans and are a major public health concern. 
Much of our knowledge of Salmonella host– pathogen in-
teractions derives from mouse models of typhoid fever 
and enterocolitis. Basic knowledge of the interaction be-
tween these zoonotic bacteria and immune cells is largely 
lacking in avian studies. After oral infection of chickens, 
Salmonella can be isolated from a number of peripheral 
organs, including the spleen, liver and reproductive tract 
and can be found residing within splenic macrophages 
in asymptomatic chickens. However, it is not known 
whether the presence of Salmonella with chicken splenic 
macrophages represents phagocytosis by this cell type or 
whether Salmonella exhibits a specific tropism for this 
cell type. To differentiate phagocytosis from active inva-
sion of cells by Salmonella Typhimurium, CSF1R- eGFP+ 
splenic MPS cells were exposed in vitro to either wild- type 
(WT) or a non- invasive ΔprgH mutant S. Typhimurium 
at a multiplicity of infection of five. Both bacterial strains 
expressed the fluorescent protein mCherry [32]. The cDC 
and macrophages were gated based on levels of FLT3 ex-
pression. Firstly, the percentage of mCherry+ cells were 
identified for each population (Figure 10a,b), and then, 
iMFI was calculated by multiplying the relative percent-
age of mCherry+ cells with the geometric mean fluores-
cence intensity (MFI) of mCherry+ populations. The 
negligible mCherry fluorescence detected in cells when 
the assay was carried out on ice indicates that lowering 
the temperature below 4°C inhibited the bacterial bind-
ing and internalization in all chicken cell types examined. 
At 41°C, each MPS population internalized the non- 
invasive mutant or wild- type strain (Figure 10). There was 
no significant difference in iMFI between the three MPS 
populations when treated with the ΔprgH mutant strain, 
suggesting that chicken cDCs can phagocytose Salmonella 
as efficiently macrophages. In contrast, based on iMFI as 
a proxy for the number of intracellular bacteria per cell, 
there was a preference for invasion by WT Salmonella of 
the CSF1R- eGFP+ FLT3−macrophage subset compared to 
both the CSF1R- eGFP+ FLT3HI cDC or the CSF1R- eGFP+ 
FLT3LOW macrophage subset. As the iMFI was signifi-
cantly higher in all MPS cell types when wild- type bacteria 
were used (Figure 10c), this indicates that active invasion 
of chicken splenic MPS mediated by type III secretion sys-
tem 1 is the major mechanism of S. Typhimurium intra-
cellular uptake.
DISCUSSION
The present study provides the first phenotypic and 
functional characterization of chicken cDCs by combin-
ing novel immunological tools to chicken cDC surface 
markers and the CSF1R- transgenic reporter chicken. We 
identified the full- length chicken FLT3 transcript and ex-
pressed chicken FLT3 protein. We used a novel anti- FLT3 
Ab to identify and characterize FLT3+ cells in post- hatch 
chickens. In the spleen FLT3HI, FLT3LOW and FLT3− sub-
populations were identified, with the former population 
co- expressing XCR1 and lacking expression of the com-
monly used chicken macrophage marker, MRC1L- B 
(KUL01 antigen). We propose that this FLT3HI XCR1+ cell 
subset likely represents the sole bona fide chicken cDC 
population. This work also highlights the value of using 
fluorescently labelled ligands to cell surface receptors, in-
cluding the chemokine XCL1 and the growth factor CSF2, 
as an alternative to antibodies for analysing immune cell 
populations.
The MPS is comprised of monocytes, macrophages and 
dendritic cells. Traditionally, these cell subsets have been 
defined by morphology, phenotypical characteristics and 
function. More recently, it has been suggested that cells 
of the can classified primarily by their ontogeny and sec-
ondarily by their location, function and phenotype [13]. 
In this system, macrophages and monocyte- derived cells 
are differentiated from dendritic cells, on the basis that the 
latter are derived from a common dendritic cell precursor 
[13,15,74]. Mammalian dendritic cells are further divided 
into plasmacytoid dendritic cells (pDC) and cDCs.
In early studies, antigen trapping chicken splenic den-
dritic cells were identified in the periphery of the splenic 
ellipsoid, surrounding the central arterioles of the white 
pulp and within germinal centres [75,76]. Antigen com-
plex trapping bursal secretory dendritic cells (BSDC), lo-
cated within medulla of bursal B- cell follicles, were also 
identified [77- 79]. A polyclonal antibody to bovine S100 
antigens and monoclonal antibody (CVI- ChNL- 74·3) to 
an unknown antigen, also recognizes bursal BSDCs [80], 
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as well as splenic ellipsoid associated cells (EAC) and 
follicular dendritic cells (FDCs) within germinal centres 
[81,82]. Based on antigen trapping function and antibody 
staining, it has been suggested that EAC are the precur-
sors to chicken FDCs in the spleen [83]. In mice, FDCs 
are derived from a non- haematopoietic stromal cell pre-
cursor [83]. We have shown that chicken FDCs and BSDC 
express high levels of both the CSF1R- transgene reporter 
and CSF1R protein [10]. This suggests that chicken FDCs 
and BSDC are part of the macrophage/monocyte lineage 
[10].
In the present study, FLT3+ MHCII+ cells were ex-
cluded from the splenic ellipsoids and germinal centres, as 
well as bursal B- cell follicles. This indicates that chicken 
BSDCs and FDCs are not FLT3+ MHCII+ cDCs, Splenic 
FLT3+ MHCII+ cDCs were abundant and restricted to 
the red pulp and periarterial lymphoid sheath (PALS) 
areas of the spleen. Anti- chFLT3 also specifically stained 
cells in the splenic ellipsoid capillary, suggesting a possi-
ble role in regulating endothelial cell development. In a 
previous study, we identified a cell population enriched 
for the expression of cDC associated genes, for example 
(FLT3, BLB2 (encoding the chicken MHC class II beta 
chain 2), XCR1, CADM1, CIITA, CD74 and IRF8) and hy-
pothesized that in comparison with the mammalian liver, 
chicken cDCs were relatively abundant [27]. The present 
study agrees with this hypothesis, as we show that FLT3+ 
MHCII+ cells (identified as chicken cDCs) were abundant 
in the liver, mainly concentrated around liver blood ves-
sels. In contrast MRC1L- B+ macrophages are not clustered 
around liver blood vessels (this study, [27]). These data in-
dicate that chicken FLT3+ cDCs are located in different 
anatomical locations to chicken FDCs, BSDCs and liver 
macrophage populations Despite anatomical differences 
between the structure of the murine and chicken spleen 
(mainly the lack of PWP in the former case), the location 
of FLT3+ MHCII+ cDCs in the chicken spleen appears to 
be similar to the reported location of XCR1+ cDCs in the 
murine spleen, which are located in T- cell areas, such as 
the PALS, and red pulp of the spleen [84,85].
Mammalian cDCs consist of two subsets: cDC1 and 
cDC2. Each cDC subset exhibits functional specialization, 
which is further influenced by tissue microenvironment 
predominately in non- lymphoid organs [12,14,15,16,72]. 
The murine cDC1  subset is specialized for cross- 
presentation of antigens and induction on Th1 responses, 
whereas the cDC2 subset is specialized for the induction 
of Th2 and Th17 immune responses [86]. Using transcrip-
tomic approaches, a cDC subset, proposed to be equivalent 
to the mammalian XCR1+ cDC1 subset, was identified in 
the CSF1R- transgene+ population in the chicken spleen, 
liver and lungs [26,27,28,29,87]. In the present study, all 
splenic FLT3HI cells expressed XCR1. In support of previ-
ous work, the vast majority (~80%) of FLT3HI XCR1+ cDCs 
were CSF1R- eGFP+. No differences were observed in cell 
surface marker expression between the CSF1R- eGFP+ and 
CSF1R- eGFP− FLT3HI XCR1+ cDCs, and both subsets ex-
pressed the same level of CSF1R protein on the cell sur-
face. This suggests that the level of CSF1R- eGFP transgene 
expression is not related to cell maturation or activation 
status. In combination with FLT3 and/or XCR1 staining, 
CSF1R- eGFP expression is very useful for characterizing 
the phenotype of chicken cDCs.
There is no evidence in the FLT3HI cell population 
that chickens have the equivalent of the mammalian 
cDC2 subset [87,88], which in any case is difficult to distin-
guish from a macrophage on the basis of markers or tran-
scriptomic profile [47]. As low- to- intermediate expression 
of FLT3 was observed on both CSF1R- eGFP negative and 
positive populations, we cannot rule out the possibility 
F I G U R E  9  Morphology and phenotype of chicken splenic dendritic cells. Chicken splenocytes were isolated from a 12- week- old CSF1R- 
eGFP+ transgenic birds and cultured in fibronectin- coated chamber slides overnight and stained for XCR1and MRC1L- B (a), XCR1 and 
MHCII (b) or XCR1 only (c). Scale bar = 10 µm
CSF1R-eGFP XCR1 KUL01(a) (b) (c)CSF1R-eGFP XCR1 MHCII CSF1R-eGFP XCR1
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that other chicken DC populations (e.g. pDCs) exist in the 
FLT3  low/intermediate fraction. Further immunological 
tools will be required to determine if this is the case.
Despite the shared expression of XCR1+, there are 
several major differences between chicken cDCs and the 
mammalian cDC1 subset. Most obviously, they are abun-
dant in chicken lymphoid tissues and both FLT3 and 
XCR1 mRNA are readily detected in total spleen and cae-
cal tonsil mRNA [44]. Indeed, in the liver, the putative 
cDC identified with the Csf1r- mApple transgene that ex-
pressed FLT3 and XCR1 mRNA were of similar abundance 
to Kupffer cells [27]. In chicken, the cDCs express high 
levels of CSF1R on their surface, but not CSF2R (Figure 
7c). CSF1R is archetypal macrophage lineage specific re-
ceptor, being the receptor for the macrophage growth fac-
tors CSF1 and IL- 34. In the chicken, as in mammals, we 
have found that in addition to the macrophages and mono-
cytes, CSF1R mRNA and reporter genes are expressed by 
granulocytes [10]. An additional novel function in birds is 
suggested by expression in epithelial- derived antigen sam-
pling M- cells [32]. Nevertheless, the relative lack of CSF1R 
expression has been used as selection criteria for identi-
fying the cDC1 subsets [47,89]. We are currently generat-
ing both CSF1R- and FLT3- deficient chickens to directly 
F I G U R E  1 0  Flow cytometric 
analysis of single, live splenic cells 
from 11- week- old CSF1R- eGFP+ birds 
(n = 3) incubated with Salmonella 
Typhimurium strain ST4/74 nalR (wild- 
type) or an isogenic mutant which 
lacks prgH (ΔprgH). Flow cytometric 
gating strategy to identify the three cell 
MPS populations was the same as in 
Figure 4. CSF1R- eGFP+FLT3HI = ‘cDC’, 
CSF1R- eGFP+FLT3LOW = ‘Mac1’) 
and CSF1R- eGFP+FLT3− = ‘Mac2’. (a 
and b) Frequency of cells expressing 
Salmonella- mCherry in each population 
(the mean ±SD). The adhesion and 
entry of Salmonella into MPS cells were 
carried out at 41°C, with duplicated 
experiment carried out on ice as controls. 
Gentamicin also used to kill bacteria 
extracellular bacteria; hence, only 
intracellular bacteria were detected by 
their expression of mCherry by flow 
cytometry. (c) Comparisons of the 
integrated mean fluorescence intensity 
(iMFI) of Salmonella- mCherry+ cells 
across different populations. Statistical 
analysis was conducted using two- tailed 
unpaired t- test with Welch correction. 
Statistical significance was always defined 
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address the requirement for these growth factors in the de-
velopment and function of chicken cDCs.
In this study, we identify the CSF1R- eGFP+ XCR1− 
FLT3LOW subpopulation as a candidate for a unique 
chicken APC population. Expression of FLT3 suggests a 
DC origin, whereas expression of the classical monocyte/
macrophage marker MRC1L- B suggests that is subset is 
a specialized macrophage population. Chicken splenic 
MRC1L- BHI MHCIILOW and MRC1L- BLOW MHCIIHI mac-
rophage subsets have recently been characterized by Yu 
and colleagues [90]. Despite subset- specific immune re-
sponses to lipopolysaccharide (LPS) stimulation, based on 
adoptive cell transfer experiments, both MRC1L- B subsets 
were suggested to have a common monocytic origin. Taken 
together, these data suggest a macrophage/monocyte 
origin for the FLT3LOW MRC1L- BLOW MHCIIHI CSF1R- 
transgene+ subset identified in this study. Irrespective of 
these ontological origins, their high- level expression of 
MHCII is consistent with the identification of this subset 
as chicken APCs.
Salmonella enterica causes disease in poultry and se-
rovars that are frequently isolated from chickens, such as 
Typhimurium and Enteritidis, also infect humans and are 
a major public health concern. Despite this, very little is 
known regarding Salmonella chicken cell tropism. After 
infection with Salmonella Pullorum, intracellular bac-
teria were detected in splenic MRC1L- B+ macrophages 
[91], and more recently, we demonstrated that Salmonella 
Typhimurium invading the bursa of Fabricius follicle- 
associated epithelium are found within TIM4+ macro-
phages [32]. Furthermore, as pathogenic bacteria (e.g. 
Mycobacterium tuberculosis, Salmonella Typhimurium, 
Yersinia enterocolitica or Escherichia coli) evade immune 
response by targeting host cells for intracellular invasion, 
the presence of intracellular bacteria does not distinguish 
between phagocytosis of bacteria by the host cell and ac-
tive invasion of host cells by intracellular pathogens. To 
distinguish between these outcomes, we compared the 
uptake of fluorescently labelled invasive wild- type and 
non- invasive ΔprgH Salmonella typhimurium by splenic 
CSF1R- transgene expressing cells. FLT3HI, FLT3LOW and 
FLT3− CSF1R- transgene expressing subpopulations ex-
pressing subpopulations were equally capable of phago-
cytosing ΔprgH S. Typhimurium. We found that S. 
Typhimurium also actively invaded all three subsets of 
splenic APC cells, but to a greater extent in the FLT3LOW 
and FLT3− CSF1R- transgene expressing subpopulations. 
As both these subsets express MRC1L- B, these data are 
consistent with the location of intracellular Salmonella 
observed in splenic MRC1L- B+ macrophages [91] after in 
vivo challenge. Nevertheless, the chicken FLT3HI XCR1+ 
cDCs were clearly also susceptible to pathogen invasion. In 
mammals, Salmonella infection modulates dendritic cell 
survival and function in a subset- specific manner [92] and 
uptake of Salmonella interferes with antigen presentation 
[93,94]. Our data paint a complex picture of Salmonella 
interactions with different APC subsets during infection 
in chickens, with Salmonella preferentially targeting mac-
rophages, but also invading cDCs and potentially inter-
fering with cDC function. To develop novel intervention 
strategies to control Salmonella and other bacterial patho-
gens in chickens, knowledge on the specific in vivo roles 
of chicken cDCs and other MPS subsets during infection 
and immunity will be required. We are currently generat-
ing chicken cDC knockout lines, which will enable these 
questions to be addressed.
Consistent with the lack of CSF2R expression on chicken 
cDCs, we show that the chicken CSF2- differentiated bone 
marrow- derived cultures do not contain cDCs. Despite the 
widespread use of BMDC as a proxy for in vivo DC pop-
ulations, both CSF2- differentiated chicken and murine 
‘BMDCs’ are comprised of a heterogeneous population 
of cells [95- 97] and there is an ongoing debate about how 
representative in vitro grown bone marrow- derived DCs 
are of their in vivo counterparts [96]. Murine CSF2 bone 
marrow cultures have been shown to contain both FLT3+ 
cDCs and monocyte- derived macrophages [96]. We show 
here that ChBMDCs also are a heterogeneous population 
that consist of two major MRC1L- B+ subsets, neither of 
which expresses FLT3 or XCR1. Therefore, the use of chB-
MDCs as functional proxies for cDCs needs to be treated 
with caution.
CONCLUSIONS
We present here a detailed analysis of chicken splenic 
APCs, using a range of novel immunological reagents 
including anti- FLT3  monoclonal antibody; XCL1AF647 
and CSF2AF647 which allowed efficient and precise iden-
tification of bona fide chicken cDCs. XCR1 expression 
was confined to the FLT3HI expressing cells. These cells 
expressed high levels of MHCII and exhibited a typical 
dendritic cell morphology in tissue sections and in vitro 
culture. By immunofluorescence staining we could dif-
ferentiate FLT3+ MHCII+ cells from previously identi-
fied chicken dendritic cell populations (e.g. FDCs and 
BSDC) and macrophages, suggesting different ontologi-
cal origins between chicken cDCs and other cells of the 
chicken MPS. Consistent with previous studies which 
have identified chicken cDCs on the basis of transcrip-
tional signature [26,27,29,87,88], these data indicate 
that the XCR1+ cDC lineage arose before the diver-
sion of the avian and mammalian lineages (last com-
mon ancestor ~320 million years ago) and has retained 
many features in common in both lineages [26,74,75], 
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suggesting a conserved role in uptake of dead cells and 
the cross- presentation of antigens [26,87,88]. Unlike 
mouse DC, which lack Timd4  mRNA [47], chicken 
cDC also express TIM4, a receptor for apoptotic cells 
[27]. XCL1 ‘tags’ dead cells, suggesting a role for XCR1- 
XCL1 interactions in the direct recognition of dead cells 
by XCR1+ cDCs, as well as the role in cell chemotaxis. 
We found significance divergence in the expression of 
growth factor receptors between the chicken and mam-
malian XCR1+ cDCs. Chicken cDCs express high levels 
of CSF1R and low levels of CSF2R, while the converse is 
true for the mammalian XCR1+ cDC1 subset. As such, 
CSF2- differentiated chicken bone marrow- derived cul-
tures do not contain cDCs. We show that despite the 
preferential invasion of macrophages by Salmonella 
Typhimurium, chicken cDCs are equality effective at the 
uptake of live non- invasive Salmonella Typhimurium. 
In mammals, XCR1+ cDCs are believed to be special-
ized for the cross- presentation of antigens and the gen-
eration of cytotoxic T- cell responses [18,21,98]. We now 
have the tools to investigate the relative contribution of 
chicken XCR1+ cDCs to host defence and the develop-
ment of acquired immunity.
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